Alternatives to Avant Genomics

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Advancing next-generation mRNA medicines.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A biotechnology company focused on oncology drug discovery.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing genetic therapies for rare disorders.

A full-stack spatial biology company.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing gene editing therapies to lower cholesterol.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing novel immunotherapies and diagnostics for cancer.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Engineering scalable gene therapies for broader patient populations.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Platform designed to cut cell and gene therapy production costs.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Pioneering vision restoration therapies for severe retinal degenerations.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing ultrasound-mediated nonviral genetic medicines.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing novel therapies to reverse aging and extend lifespan.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Developing first-in-class oral therapy for BK polyomavirus infections.

Developing epigenetic reprogramming drugs for age restoration.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Developing novel male contraceptives.

Scalable, one-time curative in-vivo gene editing therapies.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.